Upgrade to SI Premium - Free Trial

Royalty Pharma plc (RPRX)

54.86 -1.01 (1.81%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (8/12/26)

Latest Headlines

Form 4 Royalty Pharma plc For: Jun 05 Filed by: WEATHERMAN ELIZABETH H June 8, 2026 4:29 PM - SEC Filing Form 4 Royalty Pharma plc For: Jun 05 Filed by: Norden Gregory June 8, 2026 4:28 PM - SEC Filing Form 4 Royalty Pharma plc For: Jun 05 Filed by: LOVE TED W June 8, 2026 4:27 PM - SEC Filing Form 4 Royalty Pharma plc For: Jun 05 Filed by: HODGSON DAVID C June 8, 2026 4:26 PM - SEC Filing Form 4 Royalty Pharma plc For: Jun 05 Filed by: Ho Carole June 8, 2026 4:24 PM - SEC Filing Form 4 Royalty Pharma plc For: Jun 05 Filed by: Engelbert Catherine M. June 8, 2026 4:23 PM - SEC Filing Form 4 Royalty Pharma plc For: Jun 05 Filed by: Coric Vlad June 8, 2026 4:21 PM - SEC Filing Form 4 Royalty Pharma plc For: Jun 05 Filed by: Bassler Bonnie L June 8, 2026 4:20 PM - SEC Filing Form 8-K Royalty Pharma plc For: Jun 04 June 4, 2026 4:16 PM - SEC Filing Royalty Pharma to present at the Goldman Sachs 47th Annual Global Healthcare Conference June 4, 2026 4:15 PM - StreetInsider Form 4 Royalty Pharma plc For: May 26 Filed by: Coyne Terrance P. May 28, 2026 5:36 PM - SEC Filing Form 8-K Royalty Pharma plc For: May 22 May 28, 2026 4:45 PM - SEC Filing Form 144 Royalty Pharma plc Filed by: Coyne Terrance P. May 26, 2026 5:49 PM - SEC Filing Form 4 Royalty Pharma plc For: May 20 Filed by: Urist Marshall May 21, 2026 9:20 PM - SEC Filing Form 144 Royalty Pharma plc Filed by: Urist Marshall May 20, 2026 4:23 PM - SEC Filing Form 4 Royalty Pharma plc For: May 14 Filed by: Urist Marshall May 15, 2026 4:41 PM - SEC Filing Form 4 Royalty Pharma plc For: May 14 Filed by: Norden Gregory May 15, 2026 4:40 PM - SEC Filing Form 144 Royalty Pharma plc Filed by: Norden Gregory May 14, 2026 5:28 PM - SEC Filing Form 144 Royalty Pharma plc Filed by: Urist Marshall May 14, 2026 5:23 PM - SEC Filing Form 13F-NT Royalty Pharma plc For: Mar 31 May 14, 2026 2:30 PM - SEC Filing Form SCHEDULE 13G/A Royalty Pharma plc Filed by: Capital International Investors May 14, 2026 12:53 PM - SEC Filing Form 4 Royalty Pharma plc For: May 06 Filed by: Legorreta Pablo G. May 8, 2026 5:17 PM - SEC Filing Form 4 Royalty Pharma plc For: May 06 Filed by: Coyne Terrance P. May 8, 2026 5:15 PM - SEC Filing Form 4 Royalty Pharma plc For: May 06 Filed by: Hite Christopher May 8, 2026 5:12 PM - SEC Filing Form 4 Royalty Pharma plc For: May 06 Filed by: Urist Marshall May 8, 2026 5:11 PM - SEC Filing Royalty Pharma to present at upcoming investor conferences May 7, 2026 4:15 PM - StreetInsider Royalty Pharma (RPRX) PT Raised to $58 at JPMorgan May 7, 2026 9:22 AM - StreetInsider Royalty Pharma (RPRX) PT Raised to $64 at Morgan Stanley May 7, 2026 9:01 AM - StreetInsider Royalty Pharma (RPRX) PT Raised to $59 at Goldman Sachs May 7, 2026 7:40 AM - StreetInsider Form 10-Q Royalty Pharma plc For: Mar 31 May 6, 2026 9:05 AM - SEC Filing Form 8-K Royalty Pharma plc For: May 06 May 6, 2026 7:32 AM - SEC Filing Royalty Pharma reports first quarter 2026 results May 6, 2026 7:00 AM - Globe NewsWire Form 4 Royalty Pharma plc For: Apr 28 Filed by: Coyne Terrance P. April 30, 2026 5:54 PM - SEC Filing Form 144 Royalty Pharma plc Filed by: Coyne Terrance P. April 28, 2026 5:00 PM - SEC Filing Royalty Pharma Launches Global Translational Prize to Recognize Breakthrough Scientific Innovation April 21, 2026 1:00 PM - StreetInsider Royalty Pharma (RPRX) PT Raised to $57 at UBS April 21, 2026 6:35 AM - StreetInsider Royalty Pharma plc (RPRX) Declares $0.235 Quarterly Dividend; 1.9% Yield April 17, 2026 8:31 AM - StreetInsider Royalty Pharma Declares Second Quarter 2026 Dividend April 17, 2026 8:30 AM - Globe NewsWire Royalty Pharma to Announce First Quarter 2026 Financial Results on May 6, 2026 April 15, 2026 4:15 PM - StreetInsider Form 8-K Royalty Pharma plc For: Apr 13 April 13, 2026 9:53 AM - SEC Filing Form DEFA14A Royalty Pharma plc April 10, 2026 4:12 PM - SEC Filing Form ARS Royalty Pharma plc For: Dec 31 April 10, 2026 4:12 PM - SEC Filing Form DEF 14A Royalty Pharma plc For: Jun 04 April 10, 2026 4:10 PM - SEC Filing Royalty Pharma (RPRX) PT Raised to $63 at Morgan Stanley April 10, 2026 8:16 AM - StreetInsider Form 4 Royalty Pharma plc For: Apr 01 Filed by: Coyne Terrance P. April 2, 2026 5:59 PM - SEC Filing Form 144 Royalty Pharma plc Filed by: Coyne Terrance P. April 1, 2026 4:56 PM - SEC Filing Form 13F-NT Royalty Pharma plc For: Dec 31 April 1, 2026 4:42 PM - SEC Filing Form 4 Royalty Pharma plc For: Mar 31 Filed by: Bassler Bonnie L March 31, 2026 4:11 PM - SEC Filing TD Cowen on Royalty Pharma (RPRX): BIIB Ph2 results 'de-risks upside potential for royalty' March 31, 2026 8:14 AM - StreetInsider Royalty Pharma partners with J&J on $500M drug development deal March 30, 2026 7:16 AM - StreetInsider Royalty Pharma Announces R&D Funding Collaboration for Chronic Immune-Mediated Diseases March 30, 2026 7:15 AM - Globe NewsWire Royalty Pharma Announces R&D Funding Collaboration for Chronic Immune-Mediated Diseases March 30, 2026 7:15 AM - StreetInsider Form 4 Royalty Pharma plc For: Mar 23 Filed by: Coyne Terrance P. March 25, 2026 5:05 PM - SEC Filing Form 144 Royalty Pharma plc Filed by: Coyne Terrance P. March 23, 2026 4:43 PM - SEC Filing Royalty Pharma names Lucas Glass as head of artificial intelligence March 23, 2026 7:15 AM - StreetInsider Royalty Pharma Appoints Lucas Glass as Head of Artificial Intelligence March 23, 2026 7:15 AM - Globe NewsWire Royalty Pharma Appoints Lucas Glass as Head of Artificial Intelligence March 23, 2026 7:15 AM - StreetInsider Form 144 Royalty Pharma plc Filed by: Lloyd George W. March 19, 2026 5:13 PM - SEC Filing Form 144 Royalty Pharma plc Filed by: Lloyd George W. March 18, 2026 6:03 PM - SEC Filing Royalty Pharma hires Bank of America healthcare banking executive March 17, 2026 4:02 PM - StreetInsider Royalty Pharma Announces Expansion of Leadership Team March 17, 2026 4:01 PM - StreetInsider Full Article List